Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osaka Umeda Kenbi Clinic is a specialized medical facility located in Osaka, Japan, that focuses on advanced regenerative medicine and cell-based therapies. The clinic primarily provides autologous adipose-derived mesenchymal stem cell (MSC) treatments targeting orthopedic conditions such as knee osteoarthritis and systemic anti-aging. In addition to stem cell services, the clinic offers immune cell therapies, including Natural Killer (NK) cell therapy, designed for cancer prevention and as a supportive treatment for oncology patients. Operating under the Japanese Act on the Safety of Regenerative Medicine, the facility ensures high standards of cell processing and clinical administration. The clinic serves a domestic and international patient base seeking non-surgical alternatives for chronic pain and age-related degeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OSAKA UMEDA KENBI CLINIC.